Chairman of the Board Ambassador Ned L. Siegel Invests in Medbox
January 20 2015 - 7:30AM
Business Wire
Medbox, Inc. (OTCQB:MDBX) (www.medbox.com), a leading dispensary
infrastructure/licensing specialist, patented technology provider,
and partner to the cannabis industry, announced today that
Ambassador Ned L. Siegel (Ret.), Chairman of its Board of
Directors, has invested $50,000 in Medbox through the issuance of a
convertible loan.
Ambassador Siegel stated, “I believe that Medbox is in a unique
position in the cannabis industry to advise investors and
entrepreneurs as to how to obtain the required licenses to operate,
and subsequently how to manage their businesses with the highest
levels of safety, security, profitability and best practices. My
investment in the company reflects my confidence that Medbox can
build on its market positioning to generate sustainable and
profitable revenue growth.”
About Medbox, Inc.Medbox, Inc. (“MDBX” or the “Company”)
is the leading dispensary infrastructure and licensing specialist,
patented technology provider, and partner to the cannabis industry.
Headquartered in Los Angeles, CA, Medbox, through its wholly owned
subsidiary, Medicine Dispensing Systems, offers its patented
systems, software and consulting services to pharmacies,
alternative medicine dispensaries and local governments in the U.S.
In addition, through its wholly owned subsidiary, Vaporfection
International, Inc. (www.vaporfection.com), the company offers an
industry award winning medical line of vaporizer products. Medbox,
through its newly established subsidiaries, is also developing
ancillary services tailored to the alternative medicine industry,
including real estate acquisitions and subsequent lease programs to
alternative medicine dispensaries and cultivation centers, and
alternative medicine dispensary and cultivation management
services.
Forward-Looking StatementsThe statements in this press
release constitute forward-looking statements within the meaning of
federal securities laws. Such statements are based on our current
beliefs and expectations and are inherently subject to significant
business, economic and competitive uncertainties and contingencies,
many of which are beyond our control. In addition, such
forward-looking statements are subject to assumptions with respect
to future business strategies and decisions that are subject to
change. Potential risks and uncertainties include, but are not
limited to, technical advances in the industry as well as political
and economic conditions present within the industry. We do not take
any obligation to update any forward-looking statement to reflect
events or developments after a forward looking statement was
made.
Contact Information
Investor Relations:Stephen HartHayden
IR917-658-7878hart@haydenir.com
Medbox:For more information on Medbox, please call (800)
762-1452.
Hayden IRInvestor Relations:Stephen Hart,
917-658-7878hart@haydenir.com